Hans W. Nijman
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments 72
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 47
- Immunology top 0.2%
- Immunotherapy and Immune Responses 66
- Immune Cell Function and Interaction 38
- Reproductive System and Pregnancy 13
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 46
- Cancer Research top 0.5%
-
- Cervical Cancer and HPV Research 36
-
- Virus-based gene therapy research 16
- Co-authors
- Toos DaemenCornelis J.M. MeliefHans J. GeuzeGraça RaposoWillem StoorvogelClifford V. HardingNinke LeffersMarco de Bruyn
- Journals
- Proceedings of the National Academy of Sciences (2 papers)The Journal of Experimental Medicine (3 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Hans W. Nijman
196 papers receiving 13.2k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Obstetrics and Gynecology 3.0k
- Reproductive Medicine 2.3k
- Immunology 5.6k
- Oncology 4.8k
- Cancer Research 2.5k
Countries citing papers authored by Hans W. Nijman
This map shows the geographic impact of Hans W. Nijman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans W. Nijman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans W. Nijman more than expected).
Fields of papers citing papers by Hans W. Nijman
This network shows the impact of papers produced by Hans W. Nijman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans W. Nijman. The network helps show where Hans W. Nijman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans W. Nijman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 4 | |
| 10 | Tumour-infiltrating lymphocytes: from prognosis to treatment selectionbreakdown → | 2022 | 137 |
| 11 | 2020 | 42 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 0 | |
| 14 | 2019 | 167 | |
| 15 | 2018 | 33 | |
| 16 | 2017 | 129 | |
| 17 | Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohortsbreakdown → | 2016 | 569 |
| 18 | 2016 | 66 | |
| 19 | 2015 | 56 | |
| 20 | 2015 | 231 |
About Hans W. Nijman
Hans W. Nijman is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology, having authored 204 papers that have together received 13.4k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (72 papers), Immunotherapy and Immune Responses (66 papers), Ovarian cancer diagnosis and treatment (47 papers), Cancer Immunotherapy and Biomarkers (46 papers), Immune Cell Function and Interaction (38 papers), Cervical Cancer and HPV Research (36 papers), Virus-based gene therapy research (16 papers) and Reproductive System and Pregnancy (13 papers). The work is most often cited by research in Obstetrics and Gynecology (3.0k citations), Reproductive Medicine (2.3k citations) and Immunology (5.6k citations). Hans W. Nijman has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Toos Daemen, Cornelis J.M. Melief, Hans J. Geuze, Graça Raposo, Willem Stoorvogel, Clifford V. Harding, Ninke Leffers, Marco de Bruyn, Marloes J.M. Gooden and Geertruida H. de Bock. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.